The myocardial remodeling at ischemic chronic heart failure: the features of Ivabradine influence in experimental model

The myocardial remodeling at ischemic chronic heart failure: the features of Ivabradine influence in experimental model

Aim. Experimental study of Ivabradine influence on myocardial remodeling in patients with ischemic chronic heart failure. Material and Methods. The ischemic model of heart failure (HF) was modeled in 30 mature rats by isoproterenol injection. All animals were divided into 3 groups (10 each): I –...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. V. Fedorov, I. V. Kozlova, G. P. Gamorak, A. S. Geraschenko
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2016-12-01
Series:	Zaporožskij Medicinskij Žurnal
Subjects:	chronic heart failure myocardial remodeling experimental model ivabradine
Online Access:	http://zmj.zsmu.edu.ua/article/view/85500/83149
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ivabradine therapy and correction of the target organ pathology in patients with ischemic chronic heart failure
by: M. V. Surovtseva, et al.
Published: (2013-06-01)

Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction
by: S. A. Sayganov, et al.
Published: (2010-06-01)

IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

The role of cardiomyocyte apoptosis in mechanisms of ischemic myocardial remodeling
by: A. P. Khlapov, et al.
Published: (2008-09-01)

IF CHANNEL INHIBITOR IVABRADINE AND CHRONIC HEART FAILURE MANAGEMENT: FROM DISCUSSION TO ACTION
by: Yu. M. Lopatin
Published: (2012-08-01)

Ivabradine in patients with heart failure: a systematic literature review
by: Zeba M. Khan, et al.
Published: (2023-12-01)

DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
by: M. V. Surovtseva, et al.
Published: (2012-12-01)

Ivabradine therapy effectiveness in patients with chronic heart failure, Functional Class III
by: S. G. Kanorskiy, et al.
Published: (2011-04-01)

Age features of myocardial remodeling in men with ischemic chronic heart failure and renal dysfunction
by: D. A. Lashkul
Published: (2014-04-01)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE
by: M. V. Surovtseva, et al.
Published: (2015-12-01)

Long-term safety and efficacy of ivabradine after direct percutaneous coronary intervention in patients with acute myocardial infarction complicated by heart failure: a single-center retrospective study
by: Xiaohua Guo, et al.
Published: (2025-05-01)

Features of cardiac remodeling and GDF 15 and NTproBNP levels in patients with heart failure and preserved ejection fraction depending on the history of myocardial infarction
by: Ya. V. Zemlianyi, et al.
Published: (2024-10-01)

Ivabradine – a new agent for coronary heart disease treatment
by: O. A. Maneshina, et al.
Published: (2006-06-01)

CONCENTRIC MYOCARDIAL REMODELING IN CHRONIC RENAL FAILURE
by: G. V. Volgina, et al.
Published: (2001-10-01)

The Pathobiology of Myocardial Recovery and Remission: From Animal Models to Clinical Observations in Heart Failure Patients
by: Arick C. Park, et al.
Published: (2024-08-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY
by: V. V. Mazur, et al.
Published: (2016-01-01)

IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Zheleznyakova, et al.
Published: (2012-02-01)

Insulin-like Growth Factor-1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Origin
by: A. N. Zakirova, et al.
Published: (2022-11-01)

Transforming Growth Factor β1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Genesis
by: N. E. Zakirova, et al.
Published: (2021-03-01)

Modern ideas about the role of the galaninergic system in the pathogenesis of heart failure and myocardial remodeling
by: A. A. Yafarova, et al.
Published: (2023-06-01)

Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction
by: V. A. Lysenko, et al.
Published: (2021-03-01)

IVABRADINE INFLUENCE ON SYSTOLIC AND DIASTOLIC FUNCTION OF HEART VENTRICLES IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER PRIMARY REVASCULARIZATION
by: N. V. Drobotya, et al.
Published: (2014-10-01)

Features of structural and geometric remodeling of the heart and changes in heart diastolic filling in patients with chronic heart failure of ischemic genesis with reduced left ventricular ejection fraction
by: V. A. Lysenko
Published: (2021-02-01)

The effect of ivabradine as part of standard therapy on vascular endothelial function and cardiac electrical instability in patients with post-infarction cardiosclerosis and heart failure
by: A. A. Abdullaev, et al.
Published: (2020-02-01)

Twenty-year changes in the clinical and echocardiographic characteristics of patients with early postinfarction remodeling after primary ST-segment elevation myocardial infarction
by: A. M. Nikolaeva, et al.
Published: (2023-01-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

Relation of the heart remodeling and endothelial dysfunction in chronic heart failure patients
by: Ch. A. Abdullaeva, et al.
Published: (2016-02-01)

Efficacy of ivabradine in patients with poor heart rate control after beta-blocker use in acute myocardial infarction: a pragmatic randomized controlled trial
by: Yongbin Li, et al.
Published: (2025-04-01)

An overview of ivabradine
by: Tumelo Ramoleta, et al.
Published: (2016-12-01)

THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-09-01)

EFFICIENCY OF ENDOVASCULAR MYOCARDIAL REVASCULARIZATION AS A «BRIDGE» TO HEART TRANSPLANTATION IN PATIENTS WITH ISCHEMIC HEART FAILURE
by: A. B. Mironkov, et al.
Published: (2017-01-01)

Heart remodeling in patients with post-infarction cardiosclerosis at various stages of chronic heart failure
by: V. V. Masur, et al.
Published: (2008-06-01)

Myocardial remodeling in chronic heart failure with overweight and obesity taking into account the levels of total cholesterol and triglycerides
by: P. P. Bidzilya
Published: (2016-12-01)

Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
by: Tomoko Inoue, et al.
Published: (2023-03-01)

Physiological aspects of myocardial function improving during mechanical circulatory support
by: D. V. Shumakov, et al.
Published: (2019-12-01)

Age-related changes in the structural parameters of the heart and myocardial remodeling in chronic heart failure in women with overweight and obesity
by: P. P. Bidzilya
Published: (2015-10-01)

Cardiac remodeling in the acute period of Q-myocardial infarction, complicated by acute heart failure and hyperglycemia
by: V. D. Syvolap, et al.
Published: (2019-05-01)